YWQ-17136-26408
2 vaccinations
1 coded response
21 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 335 / FL
- Registered
- 2021-08-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-10
Registered in v-safe
-
2021-08-10
Dose 1 — Pfizer-BioNTech
- 2021-08-10
-
2021-08-11
Survey response — days 1–6 daily, dose 1MedDRA: Rhinorrhoea, Sneezing — Feeling: Fair · Site: Pain · Chills, Fatigue or tiredness, Diarrhea · Be unable to work or attend schoolFree text: Runny nose and sneezingMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-12
- 2021-08-13
- 2021-08-14
- 2021-08-15
- 2021-08-16
- 2021-08-17
- 2021-08-24
-
2021-08-31
Dose 2 — Pfizer-BioNTech
- 2021-08-31
-
2021-09-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-09-02
- 2021-09-03
- 2021-09-04
- 2021-09-05
- 2021-09-06
- 2021-09-07
- 2021-09-14
- 2021-09-21
- 2021-09-30
- 2021-10-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-10 | Pfizer-BioNTech | No |
| 2 | 2021-08-31 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Runny nose and sneezing
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Rhinorrhoea | ✓ | · | ✓ |
| SRO | Sneezing | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release